Amélie Marsot (1), Edith Ramain (2), Olivier Perus (2), Nicolas Simon (1) External validation of pharmacokinetic population model of alfentanil in obese patients.
|
A.H. Mohammadpour(1), S. Rezaee(2), S. Sadray(3), P. Ghaeli(4) Population pharmacokinetics of carbamazepine in Iranian epileptic and manic patients
|
Maurice J. Ahsman (1), Manon Hanekamp (2), Enno D. Wildschut (2), Dick Tibboel (2), Ron A.A. Mathot (1) Population Pharmacokinetics of Midazolam and Metabolites during Venoarterial Extracorporeal Membrane Oxygenation in Neonates
|
H. Abou hammoud(1), N. Simon(2), S. Urien(3), B. Riou(4), P. Lechat(1), F. Aubrun (5) Population Kinetic Pharmacodynamic and Logistic Regression Analysis of Intravenous Morphine Titration in Immediate Postoperative Period
|
Bizzotto R (1), Zamuner S (2), De Nicolao G (3), Cobelli C (1), Gomeni R (2) Multinomial logistic functions in Markov-chain models for modelling sleep architecture after placebo administration
|
K. Vučićević(1), B. Miljković(1), M. Pokrajac (1), M. Prostran (2), Ž. Martinović (3), R. Veličković (4), I. Grabnar(5) Effect of Valproic Acid Daily Dose on its Clearance in Adult Patients with Epilepsy – Population analysis of TDM data
|
I. Bondareva, O. Andreeva Population Pharmacokinetics of Carbamazepine and Estimation of Influencing Factors
|
Pinky Dua, Alienor Berges, Chao Chen, Roberto Gomeni ADAS-Cog Placebo Modelling in Alzheimer’s Disease
|
Jonathan Wagg and Michelle Green Estimation of cortical amyloid beta turnover rates
|
C Dansirikul1, A Staab1, L Salin2, S Haertter1, and T Lehr1 Population pharmacokinetic analysis of pramipexole extended-release formulation in Parkinson’s Disease (PD) patients
|
Klas J. Petersson(1), An M. Vermeulen(2), Lena E. Friberg(1) Could prolactin levels be a more informative predictor for clinical effect of D2-receptor antagonists than drug concentrations in the treatment of schizophrenia?
|
K. Bondareva External Validation of the Population Models for Carbamazepine Pharmacokinetics and the Individualizing Carbamazepine Dosage Regimen Procedure
|
HJ Blussé van Oud-Alblas (1), MYM Peeters (3), MJE Brill (4), CAJ Knibbe (2,3,4), J. Klein (1), D Tibboel (2), F. Weber (1) The pharmacodynamics of isoflurane in children using Bispectral index and composite auditory evoked potentials
|
Monica Simeoni, Jonathan Bullman, Chao Chen Prediction of remifentanil metabolic ratio using sparse data collected during non-steady-state infusion with rapidly changing rate
|
Marcus A. Björnsson (1,3), Åke Norberg (2), Sigridur Kalman (2), Mats O. Karlsson (3), Ulrika S.H. Simonsson (3) A two-compartment effect site model describes the Bispectral Index Score (BIS) after administration of propofol
|
Chao Chen (1), Jonathan Bullman (1), John Messenheimer (2) Concentration-Response Modelling of Adjunctive Lamotrigine Extended-Release for Primary Generalised Tonic-Clonic Seizures
|
Jeroen Diepstraten (1), Simone van Kralingen (2), Mariska Y.M. Peeters (1), Eric P.A. van Dongen (2), Bert van Ramshorst (3), Vera H.M. Deneer (1), Meindert Danhof (4) and Catherijne A.J. Knibbe(1,4) Population pharmacokinetics and pharmacodynamics of Propofol in morbidly obese patients
|
P Välitalo[1], E. Kumpulainen[1], M. Laisalmi[2], M. Lehtonen[1], A. Hooker[3], V-P. Ranta[1], H. Kokki[1,2] CSF and Plasma Pharmacokinetics of Flurbiprofen in Children
|
Bart Laurijssens Integrated analysis of Human PET data across multiple brain regions and receptors to make inferences from limited data.
|